Michael Yang

Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA.

Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ.

Therakos, Inc. develops immune cell therapies delivered through extracorporeal photopheresis. The firm’s engineers, clinicians and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes. It supports clinicians by providing products and training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for autologous immune cell therapy. The company was founded in 1984 and is headquartered in West Chester, PA.

Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.